CompareMarketResearchRequest a sample
Home / Healthcare / Organ Preservation & Perfusion Products

Healthcare · Market report

Organ Preservation & Perfusion Products Market Size, Share and Forecast 2026-2036

The global organ preservation & perfusion products market is worth USD 1.4 bn in 2026 and is forecast to reach USD 4.0 bn by 2036, growing at a 11.0% CAGR. United States is the largest country market and Normothermic machine perfusion is the largest by product segment.

USD 1.4 bnMarket size 2026
USD 4.0 bnForecast 2036
11.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global organ preservation & perfusion products market is worth USD 1.4 bn in 2026 and is forecast to reach USD 4.0 bn by 2036, growing at a 11.0% CAGR. United States is the largest country market and Normothermic machine perfusion is the largest by product segment.

ScopeSolutions, static cold-storage and transport devices, and hypothermic and normothermic machine perfusion systems and disposables used to preserve donor hearts, lungs, livers and kidneys between retrieval and transplant.
IndustryHealthcare
Value 2025USD 1.2 bn
Value 2026USD 1.4 bn
Value 2036USD 4.0 bn
CAGR 2026-203611.0%
Volume 2026169,307 units
Volume 2036435,202 units
Average price 2026USD 8,417 per unit
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Organ Preservation & Perfusion Products market size and forecast, 2026-2036

Exhibit 1The global organ preservation & perfusion products market is forecast to grow from USD 1.4 bn in 2026 to USD 4.0 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 11.0%
Organ Preservation & Perfusion Products market value, 2025 to 2036Market value by year. 2025: USD 1.2 bn; 2026: USD 1.4 bn; 2027: USD 1.6 bn; 2028: USD 1.8 bn; 2029: USD 1.9 bn; 2030: USD 2.2 bn; 2031: USD 2.4 bn; 2032: USD 2.7 bn; 2033: USD 3.0 bn; 2034: USD 3.3 bn; 2035: USD 3.6 bn; 2036: USD 4.0 bn. Compound annual growth rate 2026 to 2036: 11.0%.20251.4 bn20262.4 bn20314.0 bn203611.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 1.4 bn
2027USD 1.6 bn
2028USD 1.8 bn
2029USD 1.9 bn
2030USD 2.2 bn
2031USD 2.4 bn
2032USD 2.7 bn
2033USD 3.0 bn
2034USD 3.3 bn
2035USD 3.6 bn
2036USD 4.0 bn

Organ Preservation & Perfusion Products market segmentation

By product

Exhibit 2Normothermic machine perfusion is the largest segment by product, with 36.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Organ Preservation & Perfusion Products market share by product, 2026Share of 2026 revenue by product. Normothermic machine perfusion: 36.0%; Preservation solutions: 24.0%; Static cold-storage and transport devices: 20.0%; Hypothermic machine perfusion: 20.0%.Normothermic machine perfusion36.0%Preservation solutions24.0%Static cold-storage and transport devices20.0%Hypothermic machine perfusion20.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Preservation solutions24.0%15.2%USD 342 mn6.0%
Static cold-storage and transport devices20.0%16.0%USD 285 mn8.6%
Hypothermic machine perfusion20.0%19.2%USD 285 mn10.6%
Normothermic machine perfusion36.0%49.5%USD 513 mn14.6%

By organ

Exhibit 3Liver adds the most revenue by organ, growing from USD 399 mn in 2026 to USD 1.3 bn by 2036Estimated revenue in USD by organ, 2026 and 2036 forecast
Organ Preservation & Perfusion Products market by organ, 2026 and 2036Revenue by organ in 2026 and 2036. Liver: USD 399 mn in 2026, USD 1.3 bn in 2036, change +230%; Heart: USD 314 mn in 2026, USD 1.0 bn in 2036, change +230%; Kidney: USD 428 mn in 2026, USD 981 mn in 2036, change +129%; Lung: USD 200 mn in 2026, USD 550 mn in 2036, change +176%; Other: USD 86 mn in 2026, USD 163 mn in 2036, change +90%.20262036 forecastChangeLiver+230%399 mn1.3 bnHeart+230%314 mn1.0 bnKidney+129%428 mn981 mnLung+176%200 mn550 mnOther+90%86 mn163 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Kidney30.0%24.2%USD 428 mn8.7%
Liver28.0%32.6%USD 399 mn12.7%
Heart22.0%25.6%USD 314 mn12.7%
Lung14.0%13.6%USD 200 mn10.7%
Other6.0%4.0%USD 86 mn6.7%

By preservation method

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Static cold storage46.0%36.0%USD 656 mn8.3%
Hypothermic machine perfusion26.0%30.0%USD 370 mn12.6%
Normothermic machine perfusion20.0%26.0%USD 285 mn13.9%
Cryopreservation8.0%8.0%USD 114 mn11.0%

By component

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Perfusion devices36.0%36.0%USD 513 mn11.0%
Preservation solutions34.0%31.0%USD 484 mn10.0%
Disposables and accessories30.0%33.0%USD 428 mn12.1%

By donor type

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Brain-dead donors56.0%50.0%USD 798 mn9.8%
Donation after circulatory death34.0%38.0%USD 484 mn12.2%
Living donors10.0%12.0%USD 142 mn13.0%

Top 25 countries for organ preservation & perfusion products by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 88.0% of 2026 revenue and the 25 countries below together hold 96.4%.

Exhibit 4United States is the largest country market at USD 826 mn in 2026, and the three largest countries hold 68.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Organ Preservation & Perfusion Products market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 826 mn, 58.0%; Germany: USD 71 mn, 5.0%; United Kingdom: USD 71 mn, 5.0%; France: USD 57 mn, 4.0%; Italy: USD 43 mn, 3.0%; Spain: USD 43 mn, 3.0%; Canada: USD 43 mn, 3.0%; China: USD 43 mn, 3.0%; Japan: USD 28 mn, 2.0%; Australia: USD 28 mn, 2.0%.United States826 mn 58.0%Germany71 mn 5.0%United Kingdom71 mn 5.0%France57 mn 4.0%Italy43 mn 3.0%Spain43 mn 3.0%Canada43 mn 3.0%China43 mn 3.0%Japan28 mn 2.0%Australia28 mn 2.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 826 mn58.0%USD 2.4 bn11.2%
2GermanyUSD 71 mn5.0%USD 190 mn10.3%
3United KingdomUSD 71 mn5.0%USD 190 mn10.3%
4FranceUSD 57 mn4.0%USD 138 mn9.2%
5ItalyUSD 43 mn3.0%USD 105 mn9.4%
6SpainUSD 43 mn3.0%USD 105 mn9.4%
7CanadaUSD 43 mn3.0%USD 113 mn10.2%
8ChinaUSD 43 mn3.0%USD 178 mn15.3%
9JapanUSD 28 mn2.0%USD 65 mn8.6%
10AustraliaUSD 28 mn2.0%USD 77 mn10.4%
11NetherlandsUSD 18 mn1.3%USD 53 mn11.3%
12BelgiumUSD 15 mn1.1%USD 44 mn11.3%
13SwitzerlandUSD 14 mn1.0%USD 41 mn11.3%
14SwedenUSD 13 mn0.9%USD 36 mn11.2%
15AustriaUSD 10.0 mn0.7%USD 29 mn11.3%
16DenmarkUSD 9.0 mn0.6%USD 26 mn11.2%
17NorwayUSD 8.0 mn0.6%USD 23 mn11.2%
18South KoreaUSD 6.8 mn0.5%USD 20 mn11.2%
19BrazilUSD 5.4 mn0.4%USD 16 mn11.3%
20MexicoUSD 4.8 mn0.3%USD 14 mn11.3%
21IndiaUSD 4.4 mn0.3%USD 13 mn11.0%
22PolandUSD 3.7 mn0.3%USD 11 mn11.4%
23IsraelUSD 3.0 mn0.2%USD 8.5 mn11.0%
24ArgentinaUSD 2.4 mn0.2%USD 7.3 mn11.6%
25SingaporeUSD 2.3 mn0.2%USD 6.5 mn11.0%
Rest of worldUSD 51 mn3.6%USD 138 mn10.4%
Exhibit 5United States and China account for 65% of the USD 2.6 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Organ Preservation & Perfusion Products market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 1.4 bn. United States: +USD 1.6 bn; China: +USD 135 mn; Germany: +USD 119 mn; United Kingdom: +USD 119 mn; France: +USD 81 mn; 20 other countries: +USD 508 mn; Rest of world: +USD 86 mn. Market value 2036: USD 4.0 bn.Market value 20261.4 bnUnited States+1.6 bnChina+135 mnGermany+119 mnUnited Kingdom+119 mnFrance+81 mn20 other countries+508 mnRest of world+86 mnMarket value 20364.0 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • TransMedics
  • XVIVO Perfusion
  • Getinge
  • Terumo

Group 2: Regional and specialist players

  • Bridge to Life
  • Organ Recovery Systems
  • Essential Pharma
  • Paragonix Technologies
  • Institut Georges Lopez
  • Lung Bioengineering

Group 3: Emerging and niche players

  • Waters Medical Systems
  • Organ Assist
  • Hemarina
  • Aferetica

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the organ preservation & perfusion products market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 11.0% is calculated from the resulting values.

The market is divided by product, by organ, by preservation method, by component, by donor type. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the organ preservation & perfusion products market?

The global organ preservation & perfusion products market is estimated at USD 1.2 bn in 2025 and USD 1.4 bn in 2026.

How fast will the organ preservation & perfusion products market grow?

It is forecast to reach USD 4.0 bn by 2036, a compound annual growth rate of 11.0% from 2026, an increase of USD 2.6 bn.

Which country is the largest market for organ preservation & perfusion products?

United States is the largest market by revenue at USD 826 mn in 2026, 58.0% of the global total. The three largest countries together hold 68.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 15.3% a year from 2026 to 2036.

Which organ preservation & perfusion products segment is largest?

In the by product split, Normothermic machine perfusion is the largest segment with 36.0% of 2026 revenue.

Who are the leading organ preservation & perfusion products companies?

Global leaders include TransMedics, XVIVO Perfusion, Getinge, Terumo.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Oral Drug Delivery Organ Preservation Solution →

All Healthcare markets →

Request a sample